Medtronic Receives Regulatory Approval For Endeavor(R) Drug‐Eluting Coronary Stent In Japan

Medtronic, Inc. (NYSE: MDT), announced approval of its Endeavor drug‐eluting coronary stent system by the Japanese Ministry of Health, Labor and Welfare (MHLW), clearing the way for the highly anticipated launch of the product in the world's second largest market for advanced medical technology. Medtronic plans to launch the Endeavor drug‐eluting stent (DES) immediately following the authorization of reimbursement which is expected on May 1.